Brokerages Set Unum Group (NYSE:UNM) Price Target at $67.73

Unum Group (NYSE:UNM) has received an average rating of “Moderate Buy” from the twelve analysts that are presently covering the company, MarketBeat.com reports. Four investment analysts have rated the stock with a hold recommendation and eight have issued a buy recommendation on the company. The average 12-month target price among brokerages that have covered the stock in the last year is $67.73.

UNM has been the subject of a number of research reports. Truist Financial boosted their target price on shares of Unum Group from $70.00 to $75.00 and gave the stock a “buy” rating in a research note on Friday, November 1st. Bank of America boosted their price objective on Unum Group from $54.00 to $63.00 and gave the stock a “neutral” rating in a research note on Thursday, October 10th. Morgan Stanley raised their target price on Unum Group from $62.00 to $64.00 and gave the company an “equal weight” rating in a research report on Wednesday, October 30th. JPMorgan Chase & Co. lowered their price target on Unum Group from $65.00 to $63.00 and set an “overweight” rating on the stock in a research note on Thursday, October 3rd. Finally, Wells Fargo & Company increased their price objective on Unum Group from $69.00 to $71.00 and gave the company an “overweight” rating in a research note on Thursday, October 10th.

Insider Transactions at Unum Group

In other Unum Group news, EVP Christopher W. Pyne sold 3,250 shares of the stock in a transaction dated Wednesday, November 6th. The shares were sold at an average price of $70.02, for a total transaction of $227,565.00. Following the completion of the transaction, the executive vice president now owns 50,762 shares of the company’s stock, valued at $3,554,355.24. This trade represents a 6.02 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CAO Walter Lynn Rice, Jr. sold 1,500 shares of the business’s stock in a transaction that occurred on Thursday, November 7th. The shares were sold at an average price of $69.56, for a total transaction of $104,340.00. Following the completion of the sale, the chief accounting officer now directly owns 8,361 shares in the company, valued at $581,591.16. This trade represents a 15.21 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 107,914 shares of company stock worth $7,998,745 in the last 90 days. Insiders own 0.93% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the company. CIBC Asset Management Inc boosted its stake in shares of Unum Group by 3.4% in the third quarter. CIBC Asset Management Inc now owns 5,551 shares of the financial services provider’s stock valued at $330,000 after purchasing an additional 180 shares during the period. V Square Quantitative Management LLC lifted its holdings in Unum Group by 38.2% during the 3rd quarter. V Square Quantitative Management LLC now owns 702 shares of the financial services provider’s stock worth $42,000 after buying an additional 194 shares in the last quarter. Brooklyn Investment Group boosted its position in Unum Group by 3.1% in the 3rd quarter. Brooklyn Investment Group now owns 6,592 shares of the financial services provider’s stock valued at $392,000 after buying an additional 197 shares during the period. Benjamin F. Edwards & Company Inc. boosted its position in Unum Group by 2.2% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 10,126 shares of the financial services provider’s stock valued at $518,000 after buying an additional 217 shares during the period. Finally, Caprock Group LLC grew its stake in shares of Unum Group by 1.8% in the third quarter. Caprock Group LLC now owns 12,308 shares of the financial services provider’s stock worth $732,000 after acquiring an additional 221 shares in the last quarter. 86.57% of the stock is currently owned by institutional investors and hedge funds.

Unum Group Trading Down 1.5 %

Shares of Unum Group stock opened at $74.96 on Friday. The firm has a 50-day simple moving average of $67.66 and a two-hundred day simple moving average of $58.37. The company has a debt-to-equity ratio of 0.32, a quick ratio of 0.28 and a current ratio of 0.28. Unum Group has a fifty-two week low of $42.37 and a fifty-two week high of $77.63. The company has a market cap of $13.69 billion, a P/E ratio of 8.11, a price-to-earnings-growth ratio of 1.07 and a beta of 0.79.

Unum Group (NYSE:UNM) last released its quarterly earnings results on Tuesday, October 29th. The financial services provider reported $2.13 earnings per share for the quarter, topping analysts’ consensus estimates of $2.10 by $0.03. Unum Group had a return on equity of 15.21% and a net margin of 13.76%. The company had revenue of $3.22 billion during the quarter, compared to analysts’ expectations of $3.26 billion. During the same quarter in the prior year, the firm posted $1.94 EPS. Unum Group’s quarterly revenue was up 4.0% compared to the same quarter last year. As a group, equities analysts predict that Unum Group will post 8.53 earnings per share for the current fiscal year.

Unum Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 25th were issued a $0.42 dividend. The ex-dividend date was Friday, October 25th. This represents a $1.68 annualized dividend and a yield of 2.24%. Unum Group’s payout ratio is 18.18%.

About Unum Group

Unum Group, together with its subsidiaries, provides financial protection benefit solutions primarily in the United States, the United Kingdom, Poland, and internationally. It operates through Unum US, Unum International, Colonial Life, and Closed Block segment. The company offers group long-term and short-term disability, group life, and accidental death and dismemberment products; supplemental and voluntary products, such as individual disability, voluntary benefits, and dental and vision products; and accident, sickness, disability, life, and cancer and critical illness products.